Osteochondral lesions of the tibial plafond are extremely rare and their true incidence is difficult to estimate. [1][2][3] Most osteochondral lesions of the ankle involve the talar dome. Involvement of the tibial plafond is rare. [1] Surgical management of these lesions is technically difficult due to limited access either with open surgery or arthroscopy. [2] To the best of our knowledge, there are no published cases in the literature describing a second anterograde osteochondral autograft application in the tibial plafond. [4] The present case study includes bilateral, symmetric defects which have only been reported once in the literature. [5] This report includes revision surgery of one side, the non-symptomatic side was followed by observation.Similar to other osteochondral lesions of the talus, there are numerous possible etiologies of, particularly Graft failures of the tibial plafond are very rare. This article presents the technique of precise antegrade osteochondral auto-grafting under three-dimensional (3D) fluoroscopy. A 20-year-old athletic patient with a recurrent osteochondral lesion of the tibial plafond on a first osteochondral autograft after two years of follow-up was admitted. The revision osteochondral autograft was performed under real-time perioperative arthroscopic and 3D fluoroscopic control for greater precision. Surgery was followed by six weeks of non-weight-bearing in a walking boot. At one-year follow-up, the patient was effusion and pain free and returned to his previous activity level completely. Revision osteochondral autografting under arthroscopic and 3D fluoroscopic control seems to be an effective therapeutic option.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.